Fall 2026
What the numbers really look like, from formation to IPO.
Founders negotiate equity, dilution and terms mostly in the dark — the benchmarks that would tell them what "normal" looks like are the one thing nobody in the room shares. This course walks the startup lifecycle stage by stage against data on 40,000+ startups, and each session a stage-appropriate investor joins to say what the numbers look like from their side of the table.
Seed & First Institutional Capital
How to think about valuation when you have no revenue, and what seed investors are actually looking for
Accelerators & SAFEs
What an accelerator actually buys you, and how the SAFE became the default instrument for early-stage capital
Series A & The Institutional Transition
The step-up from first-money-in seed to Series A: seed backs a team and a thesis on almost no data, while the A prices real traction — a higher bar, a board seat, and a new level of rigor
Series B & Scaling Product-Market-Fit
Series B separates companies that found product-market fit from those that faked it — and it is when down rounds, refreshers, and secondaries enter the conversation
Crypto, Tokens & Frontier Tech Capital
What changes when equity isn’t the only asset on the table — token warrants, milestone tranches, and how capital-hungry frontier companies actually get funded
Warrants & Strategic Investors
What corporate, government, and studio investors want that financial VCs don’t — and what their paper actually costs you
Inside the Data: What 40,000 Cap Tables Actually Show
Every benchmark in this course came from somewhere. This session goes behind them — how the numbers are built, what they can and cannot tell you, and how to read a median against your own deal.
Writing The First Check
How a pre-seed fund decides with almost no data — and what the economics look like from the other side of the table
Pre-Seed: Formation & Founder Equity
Before there’s a product, there’s a cap table — the decisions that shape everything that follows
Growth Rounds & Series C and Beyond
Late-stage rounds bring new players — crossover funds, sovereign wealth, and hedge funds who think differently than VCs
The Public Markets Transition
The IPO isn’t the end — it’s a transition to a completely different game, and the data on founder and employee outcomes is rarely shown